Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta

American Journal of Medical Genetics
I M OrioliP Mastroiacovo

Abstract

The paternal ages of nonfamilial cases of achondroplasia (AC) (n = 78), thanatophoric dysplasia (TD) (n = 64), and osteogenesis imperfecta (OI) (n = 106), were compared with those of matched controls, from an Italian Indagine Policentrica Italiana sulle Malformazioni Congenite and a South American Estudio Colaborativo Latinoamericano de Malformaciones Congénitas series. The degree of paternal age effect on the origin of these dominant mutations differed among the three conditions. Mean paternal age was highly elevated in AC, 36.30 +/- 6.74 years in the IPIMC, and 37.19 +/- 10.53 years in the ECLAMC; less consistently elevated in TD, 33.60 +/- 7.08 years in the IPIMC, and 36.41 +/- 9.38 years in the ECLAMC; and only slightly elevated in OI in the ECLAMC, 31.15 +/- 9.25 years, but not in the IPIMC, 32.26 +/- 6.07 years. Increased maternal age or birth order in these conditions disappeared when corrected for paternal age. Approximately 50% of AC and TD cases, and only 30% of OI cases, were born to fathers above age 35 years. For AC and TD, the increase in relative incidence with paternal age fitted an exponential curve. The variability of paternal age effect in these new mutations could be due, among other reasons, to the high pro...Continue Reading

References

Apr 1, 1979·Journal of Medical Genetics·D O SillenceD M Danks
Jan 1, 1975·Advances in Human Genetics·F Vogel, R Rathenberg
Jul 1, 1991·Journal of Medical Genetics·P H ByersM C Willing
Dec 1, 1988·American Journal of Medical Genetics·M L Martínez-FríasJ Salvador
Sep 1, 1987·American Journal of Medical Genetics·J G HallV A McKusick
Jun 1, 1986·Journal of Medical Genetics·A D CarothersC R Paterson
Aug 1, 1986·Journal of Medical Genetics·I M OrioliJ G Barbosa-Neto
Oct 1, 1971·Archives of Disease in Childhood·M W PartingtonD G Wollin
May 1, 1984·American Journal of Medical Genetics·V M RiccardiC Bontke
Mar 1, 1994·Nature Genetics·M VelinovP Tsipouras
Mar 1, 1994·Nature Genetics·M Le MerrerA Munnich
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C J ZhengS H Moolgavkar
Aug 13, 1955·Lancet·L S PENROSE
May 1, 1956·Annals of Human Genetics·C AUERBACH
Jun 1, 1955·Annals of Human Genetics·B WOOLF

❮ Previous
Next ❯

Citations

Mar 29, 2002·American Journal of Medical Genetics·Dolores MalaspinaJack Gorman
Mar 13, 2012·American Journal of Medical Genetics. Part a·Cecília O Barbosa-BuckDenise P Cavalcanti
Nov 4, 2006·World Journal of Urology·Sarah M LambertHarry Fisch
Oct 1, 2009·Journal of Assisted Reproduction and Genetics·M J Trujillo-TiebasC Ayuso
May 21, 2013·Trends in Genetics : TIG·Catarina D Campbell, Evan E Eichler
Jun 3, 2009·Nature Reviews. Genetics·Norman Arnheim, Peter Calabrese
Jun 7, 2013·Human Molecular Genetics·Deepali N ShindeIrene Tiemann-Boege
Oct 13, 2001·Schizophrenia Bulletin·D Malaspina
Dec 6, 2000·Current Opinion in Pediatrics·P H Byers
May 23, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Helga V TorielloUNKNOWN Professional Practice and Guidelines Committee
Oct 20, 2009·Indian Journal of Orthopaedics·Risha NaharIshwar Chandra Verma
Dec 14, 2011·Asian Journal of Andrology·Zofnat Wiener-MegnaziMartha Dirnfeld
Oct 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Irene Tiemann-BoegeNorman Arnheim
Oct 13, 2010·European Journal of Pediatrics·Mariana del PinoHoracio Lejarraga
Jun 25, 2014·The Journal of Family Planning and Reproductive Health Care·Gerald Lawson, Richard Fletcher
Dec 15, 2015·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Stine Kjaer UrhojAnne-Marie Nybo Andersen
Dec 15, 2010·Topics in Companion Animal Medicine·Leslie A Lyons
Oct 20, 2010·Progress in Neurobiology·Alan S Brown
Mar 11, 2008·Best Practice & Research. Clinical Rheumatology·Geneviève BaujatMartine Le Merrer
Aug 21, 2007·Fertility and Sterility·Mbarka Dakouane GiudicelliYves Giudicelli
Feb 21, 2009·Paediatric and Perinatal Epidemiology·Anna Materna-KirylukAnna Latos-Bieleńska
Nov 22, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Karen B MoffittPeter H Langlois
Jan 24, 2015·Molecular Genetics & Genomic Medicine·Yuan XueWilliam R Wilcox
Mar 12, 2010·Birth Defects Research. Part A, Clinical and Molecular Teratology·Lilia Maria de Azevedo MoreiraMaria B P Toralles
May 30, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Claudio De FeliceGiuseppe Latini
Jul 29, 2015·Fertility and Sterility·Lena Sagi-DainMartha Dirnfeld
Feb 19, 2008·Trends in Ecology & Evolution·Tom PizzariMichael B Bonsall
May 1, 2015·Reproductive Biology and Endocrinology : RB&E·Rakesh SharmaRola F Turki
Feb 14, 2012·American Journal of Human Genetics·Anne Goriely, Andrew O M Wilkie
Jul 31, 2016·Bone·Félix FalardeauPhilippe M Campeau
Aug 31, 2016·Experimental Gerontology·Johanna Selvaratnam, Bernard Robaire
Aug 18, 2016·Bioinformatics·Eoin C WhelanStephan Olariu
Mar 17, 2001·Evolution & Development·C J ZhengB Byers
Oct 29, 2014·World Journal of Radiology·Ananya PandaArun Kumar Gupta
Feb 28, 2013·Nature Reviews. Urology·Catriona Paul, Bernard Robaire
Mar 11, 2018·Journal of Assisted Reproduction and Genetics·Alexander N Yatsenko, Paul J Turek
May 1, 1996·Nature Genetics·D M MoloneyA O Wilkie
Sep 17, 2004·American Journal of Medical Genetics. Part a·C Stoll, J Feingold
May 9, 2001·American Journal of Medical Genetics·A BlumsohnC R Paterson
Dec 7, 2018·Prenatal Diagnosis·Justin S BrandtElena Ashkinadze

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.